Skip to main content
Premium Trial:

Request an Annual Quote

StageZero Raising C$4.2M in Private Placement of Stocks, Warrants

This article has been updated to correct the gross proceeds from the purchase agreement. It is C$4.2 million, not C$2.4 million.

NEW YORK – StageZero Life Sciences has entered into a securities purchase agreement for the private placement of its common shares and warrants to purchase common shares for gross proceeds of approximately C$4.2 million (US$3.3 million), the company announced on Wednesday.

StageZero is issuing 9,375,002 common shares and warrants to purchase up to an aggregate of 9,375.002 common shares at C$.448 per share and associated warrant. Each warrant entitles its holder to purchase one common share at an exercise price of C$.56 per share over four years from the issuance date.

StageZero will use the placement's net proceeds to accelerate its global growth strategy and support further commercialization of its Aristotle mRNA-based multicancer test panel and its AVRT comprehensive telehealth program.

The private placement, exclusively managed by HC Wainwright, is expected to close on or about Nov. 26. The company previously raised C$2.7 million in 2019.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.